Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer

Table 1 Clinicopathological characteristics of 147 metastatic gastric cancer patients

Features	Frequency, n (%)
Gender
Female	37 (25.2)
Male	110 (74.8)
ECOG PS
0	32 (21.8)
1	83 (56.5)
2	32 (21.8)
Comorbidity
No	74 (50.3)
Yes	73 (49.7)
Smoking
No	69 (46.9)
Yes	78 (53.1)
Surgery
No	90 (61.2)
Yes	57 (38.8)
Type of surgery
No	90 (61.2)
Total gastrectomy	41 (27.9)
Subtotal gstrectomy	16 (10.9)
Patology
Adenocarcinom	128 (87.1)
Signet ring cell carcinom	15 (10.2)
Musinoz adenocarcinom	2 (1.4)
Mix carcinom	2 (1.4)
Diferantiation
Well	5 (3.4)
Moderate	74 (50.3)
Poorly	53 (36.1)
Signet ring cell carcinoma	15 (10.2)
Surgical margin
No operation	90 (61.2)
Positive	6 (4.1)
Negative	51 (34.7)
Tumor location
Fundus, cardia	48 (32.7)
Korpus	56 (38.1)
Antrum, pylor	43 (29.3)
De novo metastasis
No	44 (29.9)
Yes	103 (70.1)
Age group
≤ 63	74 (50.3)
> 63	73 (49.7)

ECOG PS: Eastern Cooperative Oncology Group Performance status.